NEOG
Price
$17.75
Change
+$0.31 (+1.78%)
Updated
Dec 4, 6:59 PM EST
30 days until earnings call
RVTY
Price
$91.76
Change
-$0.04 (-0.04%)
Updated
Dec 4, 3:59 PM EST
56 days until earnings call
Ad is loading...

Analysis and predictions NEOG vs RVTY

Header iconNEOG vs RVTY Comparison
Open Charts NEOG vs RVTYBanner chart's image
Neogen
Price$17.75
Change+$0.31 (+1.78%)
Volume$462.74K
CapitalizationN/A
Revvity
Price$91.76
Change-$0.04 (-0.04%)
Volume$2.56K
CapitalizationN/A
View a ticker or compare two or three
NEOG vs RVTY Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
NEOG vs. RVTY commentary
Dec 05, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEOG is a StrongBuy and RVTY is a Buy.

COMPARISON
Comparison
Dec 05, 2023
Stock price -- (NEOG: $17.76 vs. RVTY: $91.76)
Brand notoriety: NEOG and RVTY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NEOG: 51% vs. RVTY: 60%
Market capitalization -- NEOG: $3.63B vs. RVTY: $10.89B
NEOG [@Medical Specialties] is valued at $3.63B. RVTY’s [@Medical Specialties] market capitalization is $10.89B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $6.4B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEOG’s FA Score shows that 0 FA rating(s) are green whileRVTY’s FA Score has 1 green FA rating(s).

  • NEOG’s FA Score: 0 green, 5 red.
  • RVTY’s FA Score: 1 green, 4 red.
According to our system of comparison, RVTY is a better buy in the long-term than NEOG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEOG’s TA Score shows that 5 TA indicator(s) are bullish while RVTY’s TA Score has 4 bullish TA indicator(s).

  • NEOG’s TA Score: 5 bullish, 4 bearish.
  • RVTY’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NEOG is a better buy in the short-term than RVTY.

Price Growth

NEOG (@Medical Specialties) experienced а +5.84% price change this week, while RVTY (@Medical Specialties) price change was +3.98% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +4.05%. For the same industry, the average monthly price growth was +9.76%, and the average quarterly price growth was -10.76%.

Reported Earning Dates

NEOG is expected to report earnings on Mar 21, 2024.

RVTY is expected to report earnings on Jan 30, 2024.

Industries' Descriptions

@Medical Specialties (+4.05% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for NEOG with price predictions.
OPEN
A.I.dvisor published
a Summary for RVTY with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
RVTY($10.9B) has a higher market cap than NEOG($3.63B). RVTY has higher P/E ratio than NEOG: RVTY (52.36) vs NEOG (47.39). NEOG YTD gains are higher at: 16.612 vs. RVTY (-34.479). RVTY has higher annual earnings (EBITDA): 817M vs. NEOG (159M). RVTY has more cash in the bank: 1.43B vs. NEOG (239M). NEOG has less debt than RVTY: NEOG (889M) vs RVTY (4.01B). RVTY has higher revenues than NEOG: RVTY (2.8B) vs NEOG (919M).
NEOGRVTYNEOG / RVTY
Capitalization3.63B10.9B33%
EBITDA159M817M19%
Gain YTD16.612-34.479-48%
P/E Ratio47.3952.3691%
Revenue919M2.8B33%
Total Cash239M1.43B17%
Total Debt889M4.01B22%
FUNDAMENTALS RATINGS
NEOG vs RVTY: Fundamental Ratings
NEOG
RVTY
OUTLOOK RATING
1..100
187
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
10091
SMR RATING
1..100
9071
PRICE GROWTH RATING
1..100
5562
P/E GROWTH RATING
1..100
8810
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEOG's Valuation (74) in the Medical Specialties industry is in the same range as RVTY (84). This means that NEOG’s stock grew similarly to RVTY’s over the last 12 months.

RVTY's Profit vs Risk Rating (91) in the Medical Specialties industry is in the same range as NEOG (100). This means that RVTY’s stock grew similarly to NEOG’s over the last 12 months.

RVTY's SMR Rating (71) in the Medical Specialties industry is in the same range as NEOG (90). This means that RVTY’s stock grew similarly to NEOG’s over the last 12 months.

NEOG's Price Growth Rating (55) in the Medical Specialties industry is in the same range as RVTY (62). This means that NEOG’s stock grew similarly to RVTY’s over the last 12 months.

RVTY's P/E Growth Rating (10) in the Medical Specialties industry is significantly better than the same rating for NEOG (88). This means that RVTY’s stock grew significantly faster than NEOG’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEOGRVTY
RSI
ODDS (%)
Bearish Trend 1 day ago
70%
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
64%
Bearish Trend 1 day ago
63%
Momentum
ODDS (%)
Bullish Trend 1 day ago
56%
Bullish Trend 1 day ago
68%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
68%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
63%
Bullish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
69%
Advances
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 1 day ago
69%
Declines
ODDS (%)
Bearish Trend 8 days ago
70%
Bearish Trend 8 days ago
64%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 1 day ago
66%
Aroon
ODDS (%)
Bullish Trend 1 day ago
67%
Bearish Trend 1 day ago
62%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
UGIC54.100.79
+1.48%
UGI Corp
ONTO141.990.94
+0.67%
Onto Innovation
SCU12.72N/A
N/A
Sculptor Capital Management
STAA32.32-0.67
-2.03%
STAAR Surgical Company
OCUP2.89-0.10
-3.34%
Ocuphire Pharma

NEOG and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEOG has been loosely correlated with RVTY. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if NEOG jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEOG
1D Price
Change %
NEOG100%
+1.83%
RVTY - NEOG
50%
Loosely correlated
+0.53%
IQV - NEOG
43%
Loosely correlated
-0.30%
COO - NEOG
42%
Loosely correlated
-0.81%
PACB - NEOG
42%
Loosely correlated
+0.51%
KIDS - NEOG
41%
Loosely correlated
-3.93%
More

RVTY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RVTY has been closely correlated with IQV. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if RVTY jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RVTY
1D Price
Change %
RVTY100%
+0.53%
IQV - RVTY
73%
Closely correlated
-0.30%
IDXX - RVTY
68%
Closely correlated
+7.05%
COO - RVTY
68%
Closely correlated
-0.81%
ICLR - RVTY
65%
Loosely correlated
-1.01%
WST - RVTY
65%
Loosely correlated
-0.26%
More